Skip to main content

EMA Recommends Granting a Conditional Marketing Authorisation for Mosunetuzumab

Meer van European Society for Medical Oncology (ESMO)
Home

Oncologieportal

Gerelateerd

  • FDA Updates Reports of Breast Implant-Related Cancer, Illness
  • Hydrochlorothiazide Label Warns of Risk for Non-Melanoma Skin Cancers
  • Is ovarian cancer surgery stuck in the dark ages?: a commentary piece reviewing surgical technologies

Tags

  • lymphoma
  • follicular lymphoma

Suggesties

  • Role of CD19 CAR T Cells in Second Line Large B Cell Lymphoma: Lessons from Phase 3 Trials – An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
  • In AIDS-Related Lymphoma, Outcomes Worse With Hypoalbuminemia
  • A genomic?augmented multivariate prognostic model for the survival of Natural?killer/T?cell lymphoma patients from an international cohort
  • Dual Effect Identified for Arsenic in Carcinogenesis
  • Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma
  • [Comment] Second-line CAR T cells for lymphomas
  • Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma
  • [Obituary] Arthur Dale Riggs

Trending

  • Targeting EGFR in melanoma – The sea of possibilities to overcome drug resistance
  • Long-Term Survival in a Significant Proportion of Patients with a 1p/19q Codeleted Anaplastic Oligodendroglioma
  • [Corrections] Correction to Lancet Oncol 2022; 23: 888–98
  • [Corrections] Correction to Lancet Oncol 2022; 23: 304–16
  • [Correspondence] How molecularly similar are primary and metastatic tissues in renal cell carcinoma?
  • [Correspondence] Optimal molecular selection to benefit from nivolumab–ipilimumab in clear-cell renal cell carcinoma

Log in met Medi-Access

Wilt u het gehele artikel lezen?
Log in met Medi-Access om verder te lezen

Login Registreren

EMA Recommends Granting a Conditional Marketing Authorisation for Mosunetuzumab

European Society for Medical Oncology (ESMO) | Geplaatst op 17.05.2022 09:24

lymphoma
follicular lymphoma

It is intended for the treatment of adult patients with relapsed or refractory follicular lymphoma